相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Association of PD-L1 and ZEB-1 expression patterns with clinicopathological characteristics and prognosis in oral squamous cell carcinoma
Natsumi Takamaru et al.
ONCOLOGY LETTERS (2022)
PD-L1 Expression Correlated with Clinicopathological Factors and Akt/Stat3 Pathway in Oral SCC
Dong-Ho Geum et al.
LIFE-BASEL (2022)
Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin
Kotoku Kawaguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma
Rong Qiu et al.
MOLECULAR BIOLOGY REPORTS (2022)
UALCAN: An update to the integrated cancer data analysis platform
Darshan Shimoga Chandrashekar et al.
NEOPLASIA (2022)
Ezrin Contributes to the Plasma Membrane Expression of PD-L1 in A2780 Cells
Mayuka Tameishi et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Ezrin Regulates the Cell Surface Localization of PD-L1 in HEC-151 Cells
Chihiro Tanaka et al.
JOURNAL OF CLINICAL MEDICINE (2022)
PD-L1 expression in tongue squamous cell carcinoma
Naoki Akisada et al.
MEDICAL MOLECULAR MORPHOLOGY (2021)
Role of Ezrin/Radixin/Moesin in the Surface Localization of Programmed Cell Death Ligand-1 in Human Colon Adenocarcinoma LS180 Cells
Takuro Kobori et al.
PHARMACEUTICALS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Contribution of Ezrin on the Cell Surface Plasma Membrane Localization of Programmed Cell Death Ligand-1 in Human Choriocarcinoma JEG-3 Cells
Mayuka Tameishi et al.
PHARMACEUTICALS (2021)
Programmed cell death-ligand 1 expression predicts poor treatment response and prognostic value in esophageal squamous cell carcinoma patients without esophagectomy
Fang Zhang et al.
Aging-US (2021)
Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases
Camille Faure et al.
CANCER RESEARCH (2021)
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer
David M. O'Malley et al.
GYNECOLOGIC ONCOLOGY (2021)
Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells
Chihiro Tanaka et al.
MOLECULES (2021)
Expression and clinical value of PD-L1 which is regulated by BRD4 in tongue squamous cell carcinoma
Lu Zhao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Recent Findings in the Posttranslational Modifications of PD-L1
Shu-Man Li et al.
JOURNAL OF ONCOLOGY (2020)
Rho-associated protein kinase-dependent moesin phosphorylation is required for PD-L1 stabilization in breast cancer
Fanbiao Meng et al.
MOLECULAR ONCOLOGY (2020)
Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
Takuo Ogihara et al.
CANCERS (2020)
The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis
Ying-Nai Wang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival
Masaharu Noi et al.
CLINICAL AND EXPERIMENTAL DENTAL RESEARCH (2020)
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma
Ying-Hua Xie et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
R. Wendel Naumann et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Mechanisms Controlling PD-L1 Expression in Cancer
Jong-Ho Cha et al.
MOLECULAR CELL (2019)
Immunotherapy for Uterine Cervical Cancer
Masahiro Kagabu et al.
HEALTHCARE (2019)
The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells
Xiao-Dan Zhang et al.
NUCLEIC ACIDS RESEARCH (2018)
Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer
Francisco Barbara Abreu Barros et al.
BMC CANCER (2018)
The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance
Yang-chun Feng et al.
CANCER MANAGEMENT AND RESEARCH (2018)
L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription
Jin-Cheng Guo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer
Emeka K. Enwere et al.
MODERN PATHOLOGY (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Marth et al.
ANNALS OF ONCOLOGY (2017)
Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas
Opal L. Reddy et al.
DIAGNOSTIC PATHOLOGY (2017)
Pathophysiological Roles of Ezrin/Radixin/Moesin Proteins
Kotoku Kawaguchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma
Maria Vassilakopoulou et al.
CLINICAL CANCER RESEARCH (2016)
Changing paradigms in the systemic treatment of advanced cervical cancer
Krista S. Pfaendler et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
Stergios Boussios et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Regulation of ErbB2 localization and function in breast cancer cells by ERM proteins
Nagham Asp et al.
ONCOTARGET (2016)
Expression of ezrin in oral squamous cell carcinoma: Prognostic impact and clinicopathological correlations
Ali-Farid Safi et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2015)
Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers
Louisa Mezache et al.
MODERN PATHOLOGY (2015)
Expression of ezrin and moesin related to invasion, metastasis and prognosis of laryngeal squamous cell carcinoma
X. Wang et al.
GENETICS AND MOLECULAR RESEARCH (2014)
ERM proteins in cancer progression
Jarama Clucas et al.
JOURNAL OF CELL SCIENCE (2014)
Decreased Radixin Function for ATP-Binding Cassette Transporters in Liver in Adjuvant-Induced Arthritis Rats
Atsushi Kawase et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Comparison of PrestoBlue and MTT assays of cellular viability in the assessment of anti-proliferative effects of plant extracts on human endothelial cells
Magdalena Boncler et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2014)
Effect of Knockdown of Ezrin, Radixin, and Moesin on P-Glycoprotein Function in HepG2 Cells
Takashi Kano et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade
Mian He et al.
BMC CANCER (2010)
Organizing the cell cortex: the role of ERM proteins
Richard G. Fehon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Disturbed colocalization of multidrug resistance protein 2 and radixin in human cholestatic liver diseases
Hideyuki Kojima et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
Heidi Lyng et al.
BMC GENOMICS (2006)
Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma
H Kobayashi et al.
CLINICAL CANCER RESEARCH (2004)
Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis
H Kojima et al.
JOURNAL OF HEPATOLOGY (2003)
ERM proteins and merlin: Integrators at the cell cortex
A Bretscher et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes
S Kikuchi et al.
NATURE GENETICS (2002)